The FDA will drop its longtime requirement for 2 clinical trials for new drug approvals, making a single study the default standard to accelerate patient access to novel medical treatments

FDA will drop two-study requirement for new drug approvals, aiming to speed access

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals